Search Results

Displaying Results 376-400 of 448 "'ASC'"

Nov 04, 2025, 09:00 ET Harmoni Towers Completes Landmark $620 Million Wireless Tower Private Placement Financing

www.palistar.com.  Media ContactsMary Beth Grover / Keely Gispan ASC [email protected] / [email protected](203)

More news about: Harmoni Towers


Nov 04, 2025, 07:00 ET Harley-Davidson Delivers Third Quarter Financial Results

represent the LiveWire reportable segment as determined in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 280 Segment Reporting which may differ from LiveWire Group, Inc. results.

More news about: Harley-Davidson, Inc.


Nov 04, 2025, 06:30 ET Hut 8 Reports Third Quarter 2025 Results

unconsolidated joint venture in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income in accordance with ASC 323. See Note 10. Investments in unconsolidated joint venture of our Unaudited Condensed Consolidated Financial Statementsfor further

More news about: Hut 8 Corp.


Nov 03, 2025, 15:00 ET Dr. Max D. Schlesinger Joins OCLI Vision in Mineola and Rockville Centre

provides a comprehensive set of business support functions, including billing and collections, credential services, marketing, physician recruitment, ASC development, financial and accounting services, benefits and payroll management, and information technology. The company's corporate service center is

More news about: OCLI Vision


Nov 03, 2025, 10:15 ET Dr. Andrea N. Nortey Joins OCLI Vision in Mineola and Oceanside

provides a comprehensive set of business support functions, including billing and collections, credential services, marketing, physician recruitment, ASC development, financial and accounting services, benefits and payroll management, and information technology. The company's corporate service center is

More news about: OCLI Vision


Nov 03, 2025, 10:01 ET AmeriWater Is Expanding Its Industry-Leading ST108 Sterile Processing Water Solutions Portfolio Again, by Adding an All-in-One Solution

system design and data driven insights to ensure water quality and regulatory compliance. Key Benefits for ASC and SPD Clients Include: At Least 25% Space Savings Based on Industry

More news about: AmeriWater


Oct 30, 2025, 14:42 ET Two Seas Capital Comments on Outcome of Special Meeting of Core Scientific Shareholders

Contacts MediaSteve Bruce / Taylor Ingraham / Keely GispanASC [email protected](203) 992-1230

More news about: Two Seas Capital


Oct 30, 2025, 09:03 ET BillingPlatform Launches AI Monetization Offering to Help AI Companies Capitalize on Consumption-based Business Models

integrations with leading AI platforms. Global Compliance and Scale – Built-in tax, revenue recognition (ASC 606) and regulatory compliance for more than 180 countries. Proven Enterprise Scale – Trusted

More news about: BillingPlatform


Oct 30, 2025, 08:15 ET Silicom Reports Q3 2025 Results

(*) Adjustments related to share-based compensation expenses according to ASC topic 718 (SFAS 123 (R))

More news about: Silicom Ltd.


Oct 30, 2025, 07:00 ET International Paper Reports Third Quarter 2025 Results

our business segments and assessing the performance of our business segments and is presented in our financial statement footnotes in accordance with ASC 280 - "Segment Reporting". Third quarter 2025 net sales by business segment and operating profit (loss) by business segment compared with the second

More news about: International Paper


Oct 29, 2025, 20:10 ET Ascletis Selects a Best-in-Class Once-Monthly Subcutaneously Administered Amylin Receptor Agonist, ASC36, for Clinical Development

ASC36 has excellent chemical and physical stability with no fibrillation around neutral pH, allowing for co-formulation with other peptides including ASC35, a GLP-1R/GIPR dual agonist. ASC36's longer observed half-life, better SQ

More news about: Ascletis Pharma Inc.


Oct 29, 2025, 20:10 ET 歌禮選定同類最佳每月一次皮下注射胰澱素受體激動劑ASC36進入臨床開發階段

ASC36具有優越的理化穩定性,在中性pH值附近不形成纖維化(no fibrillation around neutral pH),可與包括GLP-1R/GIPR雙靶點激動劑ASC35在內的其他多肽藥物開發復方制劑。 ASC36具有更長的表觀半衰期、更高的皮下生物利用度及更優越的減重效果,這些優勢表明其有望成為同類最佳、每月一次的肥胖症療法。

More news about: 歌禮製藥有限公司


Oct 29, 2025, 16:15 ET MGM RESORTS INTERNATIONAL REPORTS THIRD QUARTER 2025 FINANCIAL AND OPERATING RESULTS

transactions, net, goodwill impairment, net gain/loss related to equity investments for which we have elected the fair value option of ASC 825 and equity investments accounted for under ASC 321 for which there is a readily determinable fair value and net gain/loss related to our investments in debt securities, foreign

More news about: MGM Resorts International


Oct 29, 2025, 16:05 ET MGIC Investment Corporation Reports Third Quarter 2025 Results

these ordinary course disputes and legal proceedings will not have a material adverse effect on our financial condition or results of operations. Under ASC 450-20, until a loss associated with settlement discussions or legal proceedings becomes probable and can be reasonably estimated, we do not accrue an

More news about: MGIC Investment Corporation


Oct 29, 2025, 06:30 ET CVS HEALTH CORPORATION REPORTS THIRD QUARTER 2025 RESULTS AND UPDATES FULL-YEAR 2025 GUIDANCE

Care Benefits segment The Health Care Benefits segment offers a full range of insured and self-insured ("ASC") medical, pharmacy, dental and behavioral health products and services. The segment results for the three and nine months ended September 30, 2025 and

More news about: CVS Health


Oct 28, 2025, 14:30 ET RADCOM Launches High-Capacity User Analytics Solution

overall understanding of the Company's financial performance. By excluding non-cash stock-based compensation that has been expensed in accordance with ASC Topic 718, financial income (expenses), acquisition-related expenses, and amortization of intangible assets related to acquisitions,  the Company's non-GAAP

More news about: RADCOM Ltd.


Oct 28, 2025, 08:30 ET Two Seas Capital Expresses Enthusiasm for Core Scientific's Future Prospects

[email protected](212) 750-5833 MediaSteve Bruce / Taylor Ingraham / Keely GispanASC [email protected](203) 992-1230

More news about: Two Seas Capital


Oct 27, 2025, 16:05 ET Whirlpool Corporation Announces Third-Quarter Results; Delivers Revenue Growth

our consolidated EBIT broken down by the Company's reportable segments and are metrics used by the chief operating decision maker in accordance with ASC 280. Consolidated EBIT also includes corporate "Other/Eliminations" of $(32) million and $(45) million for the third quarters of 2025 and 2024, respectively.

More news about: Whirlpool Corporation


Oct 27, 2025, 16:05 ET Welltower Reports Third Quarter 2025 Results

include unamortized premiums/discounts, other fair value adjustments and financing lease liabilities. Excludes operating lease liabilities related to ASC 842 of $1,203,954,000 and $301,046,000 for the three months ended September 30, 2025 and 2024, respectively.

More news about: Welltower Inc.


Oct 27, 2025, 08:33 ET Loon Raises $3 Million to Build Canada's Regulated Digital Dollar; Acquires CADC Stablecoin

for transparency and regulation Loon has pre-filed a prospectus with the Alberta Securities Commission (ASC) as a first step toward full regulatory approval. The company is collaborating with regulators to establish rigorous standards and accountability for

More news about: Loon


Oct 27, 2025, 06:00 ET 歌禮將攜ASC30口服片、ASC30注射劑和ASC31與ASC47聯合療法的研究結果亮相2025年肥胖周(ObesityWeek®)

ASC30 ASC30是一款正在臨床研究中的小分子GLP-1R偏向激動劑,具有獨特和差異化性質,使得同一小分子同時適用於口服片劑和皮下注射給藥成為可能。ASC30是一種新化學實體(NCE),擁有美國和全球化合物專利保護,專利保護期至2044年(不含專利延期)。 關於 ASC31

More news about: 歌禮製藥有限公司


Oct 27, 2025, 06:00 ET Ascletis to Present Study Results of ASC30 Oral Tablet, ASC30 Injection, and Combination of ASC31 and ASC47 at ObesityWeek® 2025

/PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces multiple poster presentations of its obesity assets including ASC30, and combination of ASC31 and ASC47 at ObesityWeek® 2025 in Atlanta, Georgia. Presentation Details:

More news about: Ascletis Pharma Inc.


Oct 23, 2025, 16:05 ET Digital Realty Reports Third Quarter 2025 Results

represent the sum of straight-line rental revenue and straight-line rental expense, as well as the amortization of above- and below-market leases (i.e., ASC 805 adjustments).

More news about: Digital Realty Trust


Oct 22, 2025, 16:39 ET Veris Residential, Inc. Reports Third Quarter 2025 Results

2 The sum of property level revenue, straight line and ASC 805 adjustments; less: operating expenses, real estate taxes and utilities. These are shown at 100% and include management fees.

More news about: Veris Residential, Inc.


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.